When you and your doctor make a plan to treat your neuroendocrine ... The cancer is in the lung and is typically a few centimeters (cm) in size, but smaller than about 3 inches..

This is either a grade 3 NET (WD NET G3a) or a neuroendocrine carcinoma (Poorly differentiated (PD) NEC G3). The stage of a neuroendocrine cancer tells you about its size and whether it has spread.

have advanced metastatic disease that has progressed on at least one prior line of available therapy and have a confirmed diagnosis of grade 3 well-differentiated neuroendocrine tumor or poorly ...

A panelist discusses how the CABINET trial was a National Cancer Institute (NCI)–supported study conducted by the Alliance ...

Patients diagnosed with high-grade gastroenteropancreatic neuroendocrine tumors (NETs ... for patients with higher-grade 2 or higher-grade 3, well-differentiated, advanced gastroenteropancreatic ...

with 3 indicating tumors with higher proliferation indexes) were eligible. Patients with poorly differentiated neuroendocrine carcinoma and those with high-grade neuroendocrine carcinoma without ...

The study evaluated the use of RLT earlier as a first-line (or "up front") treatment for patients newly diagnosed with grade 2 or 3 advanced gastrointestinal neuroendocrine tumors. Although ...

Adverse events of grade 3 or higher occurred in 35.6% of patients ... Administration for use in gastroenteropancreatic neuroendocrine tumors. Now with this study showing a benefit of combined ...

today announced positive topline results from its Phase 3 COMPETE trial in patients with inoperable, progressive Grade 1 or Grade 2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

3 NET are rare but increasingly diagnosed tumors that originate from neuroendocrine cells of the ... trial—regardless of primary tumor site and grade. This FDA approval marks a meaningful ...

Phase 3 clinical trial with ITM ... The trial enrolled 309 patients with Grade 1 or Grade 2 inoperable, progressive, somatostatin receptor-positive neuroendocrine tumors of gastroenteric or ...